Skip to content

Changes of the Neuronal Activity in the Subthalamic Nucleus Under Remifentanil Sedation During Stereotactic Electrode Implantation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00588926
Enrollment
20
Registered
2008-01-09
Start date
Unknown
Completion date
Unknown
Last updated
2008-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of Remifentanil, Movement Disorders

Keywords

Deep Brain Stimulation, Movement Disorders, Remifentanil, Sedation, Basal Ganglia electrical activity

Brief summary

Deep brain stimulation is commonly used for the treatment of movement disorders. Electrode positioning is usually performed under local anesthesia in fully awake patients. The procedure is uncomfortable to the patients who has to remain motionless during the whole surgery. Previous reports of electrode positioning under general anesthesia was found to be less accurate. This result was probably due to the effect of the anesthetics on the electrical activity of the basal ganglia. The purpose of this study is to detect possible changes in the electrical activity of the basal ganglia related to remifentanil sedation. electrical activity of single neurons will be recorded before, during and after sedation.

Interventions

DRUGRemifentanil

After the mapping electrode is in situ, recording of baseline electrical activity is done for two-three minutes and an infusion of Remifentanil, 0.1 microgram per kilogram per minute is started. This procedure continues for a few minutes until the patient is sedated and then the infusion is stopped and the patient allowed to recover. The recordings continue during the whole procedure.

Sponsors

Hadassah Medical Organization
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients with movement disorder, who are candidates for implantation of deep brain stimulation electrode.

Exclusion criteria

* Suspected difficult intubation * history of sleep apnea * known allergy for remifentanil

Design outcomes

Primary

MeasureTime frame
Electrical activity in the basal gangliaDuring the experiment

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026